Rainer Orth <[email protected]> writes:

> Hi Andi,
>
>> On Wed, Dec 17, 2025 at 02:04:43PM +0100, Rainer Orth wrote:
>>> Here's the adjusted patch:
>>> 
>>> Rather than skipping the gcc.target/i386/shift-gf2p8affine-2.c test on
>>> Solaris with as, it should require the necessary ISA extensions instead.
>>> 
>>> Tested on i386-pc-solaris2.11 (as and gas), x86_64-apple-darwin17.7.0,
>>> and x86_64-pc-linux-gnu.
>>> 
>>> Ok for trunk?
>>> 
>>> I won't assume this is obvious any longer ;-)
>>
>> It would under test because effective-target is for runtime, so 
>> if the assembler supports it and the CPU doesn't it would wrongly
>> reject.
>
> you don't seem to have read what I wrote:
>
> * The runtime part is dealt with by test itself using
>
>   if (!__builtin_cpu_supports ("gfni"))
>     return 0;
>
> * I have no idea where you get the idea that effective-target keywords
>   are for runtime.  As I mentioned, the implementation in
>   target-supports.exp is
>
> # Return 1 if gfni instructions can be compiled.
> proc check_effective_target_gfni { } {
>     return [check_no_compiler_messages gfni object {
>       typedef char __v16qi __attribute__ ((__vector_size__ (16)));
>
>       __v16qi
>       _mm_gf2p8affineinv_epi64_epi8 (__v16qi __A, __v16qi __B, const int __C)
>       {
>           return (__v16qi) __builtin_ia32_vgf2p8affineinvqb_v16qi ((__v16qi) 
> __A,
>                                                                    (__v16qi) 
> __B,
>                                                                     0);
>       }
>     } "-mgfni" ]
> }
>
>   This is a test if the code above can be *assembled* (see the object
>   part above), no runtime check involved.
>
>> We don't really have a effective-assembler-target, but it would be the 
>> right thing to have here.
>
> You're certainly wrong here.  Please check the facts first.

given that Andi's concerns are unfounded, I've now committed the patch.

        Rainer

-- 
-----------------------------------------------------------------------------
Rainer Orth, Center for Biotechnology, Bielefeld University

Reply via email to